Biomea Fusion BMEA
NASDAQ BMEA
$0.58 +0.03 (+5.92%)
As of: Nov 11, 2026 · 11:17 AM EST

Biomea Fusion (BMEA) Short term Debt (2020 - 2021)

Updated

Biomea Fusion's Short term Debt was $36,000 in Q1 2021, unchanged from the prior quarter.

Analysis

Biomea Fusion (BMEA) Short term Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biomea Fusion 39.97 Mn -121.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 36,000.00
Dec 31, 2020 36,000.00
API Access

Biomea Fusion Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BMEA&period=max&api_key=YOUR_API_KEY